Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Prospective Research Investigation of Ischemia Using MCG

NCT: NCT06481943 · RECRUITING

NCT IDNCT06481943
StatusRECRUITING
Start Date2024-07-11
Completion2027-02
SponsorSB Technology, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

PRISM is a prospective, pilot research study that aims to systematically characterize the usefulness of CardiAQ MCG, a bedside magnetocardiography device, in the evaluation of myocardial ischemia and infarction status.

Frequently Asked Questions

What is A Prospective Research Investigation of Ischemia Using MCG?

A Prospective Research Investigation of Ischemia Using MCG is a clinical trial registered under NCT06481943. Current status: RECRUITING.

What is the status of NCT06481943?

The current status of NCT06481943 (A Prospective Research Investigation of Ischemia Using MCG) is: RECRUITING.

When did A Prospective Research Investigation of Ischemia Using MCG start?

A Prospective Research Investigation of Ischemia Using MCG started on 2024-07-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑